Tenderfy

Supply, Delivery, Installation, Commissioning and Post-Warranty Maintenance of Digital PCR (dPCR) System for Haemoto-oncology Assays

Committente
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
Pubblicato
2026-11-16
Scadenza
2026-12-16T13:00:00+00:00
Fonti
UK_FTS
Valore
270000.0 GBP

Descrizione

La descrizione è nella lingua della fonte.

The Cambridge Genomics Lab provides a comprehensive range of genomic testing for patients with haematological malignancies (haem-onc), with solid cancer, and with rare disease. In the haem-onc setting, we currently utilise a range of molecular techniques including Next-generation sequencing, quantitative PCR, and fragment analysis to identify and monitor clinically significant genomic alterations. However, there is an increasing requirement for high sensitivity, quantitative molecular testing both to support diagnosis and for disease monitoring / assessment of therapeutic response. We are therefore looking to procure a Digital / Digital Droplet (dPCR / ddPCR) system to complement the laboratory’s existing molecular testing capabilities. This would also intend to facilitate the consolidation of multiple existing assays and methodologies onto a single technology platform.

CPV: 38950000

Abbonamento

Leggi gratuitamente le anteprime. I collegamenti ai bandi ufficiali e ai documenti, i permessi edilizi e l’accesso MCP personale richiedono un abbonamento a pagamento attivo.

Leggi